Live Breaking News & Updates on Rare Kidney Diseases

Stay updated with breaking news from Rare kidney diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PROTECT Drugs Tied to Slower eGFR Decline vs Standard Care in IgA Nephropathy

Slower kidney function decline observed with sparsentan and irbesartan ....

New York , United States , Chee Kay Cheung , National Kidney Foundation Spring Clinical , National Kidney Foundation , Rare Kidney Diseases , Leicester General Hospital , New York City , United Kingdom Radar Iga ,

Irbesartan, Sparsentan Treatment Demonstrate Significantly Slower Kidney Function Decline Compared with SoC

Irbesartan, Sparsentan Treatment Demonstrate Significantly Slower Kidney Function Decline Compared with SoC
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Wu Gong , Researchgate Wu Gong , University Of Leicester , Analysis Group , Ohio State University , National Kidney Foundation , Travere Therapeutics , United Kingdom National Registry , Rare Kidney Diseases ,

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

/PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual. ....

United States , United Kingdom , Jonathan Barratt , Garethj Thomas , Gareth Thomas , American Society Of Nephrology Kidney Health Initiative , University Of Leicester , Iga Nephropathy Network , Renal Research Group , Phd University Hospital Southampton , University Of Southampton , Life Sciences , Rare Disease Group , Inderes Event Studio , University Hospital Southampton , Experimental Pathology , United Kingdom National Registry , Rare Kidney Diseases , In Ternational Iga Nephropathy , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Iga Nephropathy Work , Calliditas Therapeutics ,

Calliditas Therapeutics: In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

STOCKHOLM, May 16, 2024 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual R&D day ....

United States , United Kingdom , Jonathan Barratt , Garethj Thomas , Gareth Thomas , Phd University Hospital Southampton , Renal Research Group , Life Sciences , University Of Leicester , American Society Of Nephrology Kidney Health Initiative , Iga Nephropathy Network , University Of Southampton , Rare Disease Group , Inderes Event Studio , University Hospital Southampton , Experimental Pathology , United Kingdom National Registry , Rare Kidney Diseases , In Ternational Iga Nephropathy , Chief Investigator , American Society , Nephrology Kidney Health Initiative , Identifying Surrogate Endpoints , Clinical Trials , Iga Nephropathy Work , Ihr Portfolio ,